Strategy Fellow
SynX Therapeutics · London / remote · 3 months, full-time · Start ASAP, Summer 2026
About SynX Therapeutics
SynX Therapeutics is a biotechnology start-up using non-canonical biology and AI to build an ultra-rapid lab-in-the-loop platform for peptide therapeutics. Our SynPeps™ combine the targeting precision of biologics with PK/delivery properties closer to small molecules, opening therapeutic opportunities that antibodies and small molecules cannot reach. SynX raised a pre-seed round from top VC and life science investors and is operating with a 5-person team from its premises in central London.
The role
We're looking for a Strategy Fellow to help us turn our platform's differentiation into a sharp, investment-grade drug target portfolio. You'll work directly with our CEO on a highly strategically important project: the curated drug target list and accompanying Target Product Profiles (TPPs) that anchor our Seed strategy.
This is a high-ownership, high-impact role: your work will directly shape our first therapeutic programs. It is a rare opportunity to combine deep scientific reasoning and commercial judgement in an entrepreneurial context. You will gain broad exposure to different disease areas, think critically about how a new modality can solve medical challenges and improve care for patients, and sharpen your scientific, commercial, and strategic instincts.
What you'll do
Critically review our differentiation thesis and target discovery framework
Run our AI-augmented target discovery workflow at scale across a candidate target universe
Map indication expansion logic and commercial upside for top targets (break-in indication → expansion path → licensing-readiness inflection points)
Build the competitive landscape view for top targets — clinical pipeline, mechanism overlap, white space.
Document your process and findings in sharp written deliverables and presentation materials
Prepare materials for strategic discussions and external stakeholders
What we're looking for
Relevant backgrounds include:
PhD in life sciences with an interest in the intersection of medical and commercial questions and entrepreneurship,
MD with strong scientific fluency,
Pharma or biotech operator with experience in indication strategy, portfolio strategy, translational development, or commercial assessment, or
Other backgrounds that combine strong biomedical judgment with strategic and commercial instincts
Specifically, you should bring:
Fluency with primary scientific literature: you can read clinical and biomedical research papers and form your own view
Commercial instincts: you think in terms of unmet need, competitive landscape, and commercial attractiveness
Strong writing: your drafts should land on a partner's desk and read like a memo, not an academic literature review
Self-direction: you'll work with autonomy on challenging medical and commercial questions
Confidentiality: you'll be handling sensitive strategy material and are comfortable treating it as such
Logistics
Duration: 3 months full-time. Extensions possible depending on project need on a case by case basis.
Start: ASAP, likely summer 2026
Compensation: Pro rata on a £50-70k pa basis depending on experience; higher for exceptional candidates
Location: In person from our London office or remote
Reports to: CEO
Notice to recruitment agencies: SynX Therapeutics does not accept unsolicited CVs from third parties. Submissions without a written agreement create no contract or fee obligation. Any candidate sourced this way will be considered a free referral, and SynX Therapeutics may use the information at its discretion.
Apply To This Job